[EN] SMALL MOLECULE INHIBITORS OF NAVL.7 SODIUM CHANNELS FOR THE TREATMENT OF PAIN DISORDERS [FR] INHIBITEURS À PETITES MOLÉCULES DE CANAUX SODIQUES NAVL.7 POUR LE TRAITEMENT DE DOULEURS
[EN] SMALL MOLECULE INHIBITORS OF NAVL.7 SODIUM CHANNELS FOR THE TREATMENT OF PAIN DISORDERS [FR] INHIBITEURS À PETITES MOLÉCULES DE CANAUX SODIQUES NAVL.7 POUR LE TRAITEMENT DE DOULEURS
[EN] HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS<br/>[FR] ACIDES HETEROARYLALCANOIQUES EN TANT QU'ANTAGONISTES DU RECEPTEUR D'INTEGRINE
申请人:PHARMACIA CORP
公开号:WO2004058254A1
公开(公告)日:2004-07-15
The present invention relates to pharmaceutical compositions comprising compounds of the Formula I, or a pharmaceutically acceptable salt thereof, and methods of selectively inhibiting or antagonizing the ανβ3 and/or the ανβ5 integrin without significantly inhibiting the ανβ6 integrin.
[EN] SMALL MOLECULE INHIBITORS OF NAVL.7 SODIUM CHANNELS FOR THE TREATMENT OF PAIN DISORDERS<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE CANAUX SODIQUES NAVL.7 POUR LE TRAITEMENT DE DOULEURS
申请人:ASTRAZENECA AB
公开号:WO2009005460A1
公开(公告)日:2009-01-08
The present invention relates to 2 -substituted, 1,1- diarylethanol compounds of formula I, which are inhibitors of the sodium channel NaVl.7, and the use of such compounds in the manufacture of medicaments for the treatment of pain.